Patents by Inventor Joseph Ferraro
Joseph Ferraro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11166929Abstract: The present invention is directed toward fatty acid-based particles, and methods of making such particles. The particles can be associated with an additional, therapeutic agent. Also provided herein is a method of forming fatty acid particles, comprising associating a cross-linked, fatty acid-derived biomaterial with a cryogenic liquid; and fragmenting the bio material/cryogenic liquid composition, such that fatty acid particles are formed. The particles can be used for a variety of therapeutic applications.Type: GrantFiled: October 19, 2018Date of Patent: November 9, 2021Assignee: ATRIUM MEDICAL CORPORATIONInventors: Thomas M. Swanick, Joseph Ferraro, Lisa Rogers, Paul Martakos
-
Patent number: 11083823Abstract: Exemplary embodiments of the present invention provide adhesion barriers having anti-adhesion and tissue fixating properties. The adhesion barriers are formed of fatty acid based films. The fatty acid-based films may be formed from fatty acid-derived biomaterials. The films may be coated with, or may include, tissue fixating materials to create the adhesion barrier. The adhesion barriers are well tolerated by the body, have anti-inflammation properties, fixate, well to tissue, and have a residence time sufficient to prevent post-surgical adhesions.Type: GrantFiled: November 17, 2017Date of Patent: August 10, 2021Assignee: ATRIUM MEDICAL CORPORATIONInventors: Thomas M. Swanick, Joe Bienkiewicz, Joseph Ferraro, Paul Martakos, Keith M. Faucher, Alicia Dale
-
Patent number: 10869902Abstract: A cured non-polymeric gel including a plurality of non-polymeric cross-links. The non-polymeric cross-links result from curing an oil or oil composition at selected curing conditions to achieve a desired amount of cross-linking to form the non-polymeric gel. The desired amount of cross-linking is selected based on a desired rate of degradation of the gel after the gel is implanted. The oil or oil composition comprises one or more of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), or alpha-linolenic acid (ALA).Type: GrantFiled: December 14, 2017Date of Patent: December 22, 2020Assignee: ATRIUM MEDICAL CORPORATIONInventors: Roger Labrecque, Philip McNamara, Joseph Ferraro, Lisa Rogers, Paul Martakos, Theodore Karwoski, Steve A. Herweck, Keith M. Faucher, Thomas M. Swanick
-
Patent number: 10792312Abstract: A barrier layer and corresponding method of making provide anti-inflammatory, non-inflammatory, and anti-adhesion functionality for a medical device implantable in a patient. The barrier layer can be combined with a medical device structure to provide anti-adhesion characteristics, in addition to improved healing, non-inflammatory, and anti-inflammatory response. The barrier layer is generally formed of a naturally occurring oil, or an oil composition formed in part of a naturally occurring oil, that is at least partially cured forming a cross-linked gel. In addition, the oil composition can include a therapeutic agent component, such as a drug or other bioactive agent.Type: GrantFiled: September 20, 2017Date of Patent: October 6, 2020Assignee: ATRIUM MEDICAL CORPORATIONInventors: Joseph Ferraro, Lisa Rogers, Paul Martakos, Theodore Karwoski, Steve Herweck, Keith Faucher, Phillip McNamara
-
Patent number: 10772995Abstract: Fatty acid-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.Type: GrantFiled: October 20, 2017Date of Patent: September 15, 2020Assignee: ATRIUM MEDICAL CORPORATIONInventors: Keith M. Faucher, Hui Tang, Joseph Ferraro, Paul Martakos, Theodore Karwoski, Scott Corbeil
-
Publication number: 20200171213Abstract: Fatty acid-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.Type: ApplicationFiled: October 20, 2017Publication date: June 4, 2020Applicant: ATRIUM MEDICAL CORPORATIONInventors: Keith M. FAUCHER, Hui TANG, Joseph FERRARO, Paul MARTAKOS, Theodore KARWOSKI, Scott CORBEIL
-
Patent number: 10285964Abstract: The present invention is directed toward fatty acid-based particles, and methods of making such particles. The particles can be associated with an additional, therapeutic agent. Also provided herein is a method of forming fatty acid particles, comprising associating a cross-linked, fatty acid-derived biomaterial with a cryogenic liquid; and fragmenting the bio material/cryogenic liquid composition, such that fatty acid particles are formed. The particles can be used for a variety of therapeutic applications.Type: GrantFiled: July 22, 2016Date of Patent: May 14, 2019Assignee: ATRIUM MEDICAL CORPORATIONInventors: Thomas M. Swanick, Joseph Ferraro, Lisa Rogers, Paul Martakos
-
Publication number: 20190133353Abstract: A multi-chamber shot container including a hand-held body that defines a first aperture disposed proximal to an upper end of the hand-held body, a second aperture, and an upper fluid aperture disposed at the upper end of the hand-held body. The shot container also includes an inner container member with an inner surface and a bottom surface enclosing and defining a first cavity spanning from the bottom surface of the inner container member to the upper fluid aperture and an outer container member with an inner surface and a bottom surface enclosing and defining, with an outer surface of the inner container member, a second cavity liquidly segregated from the first cavity, wherein the first and second apertures are in sole fluid communication with the second cavity, thereby enabling selective discharge of liquid housed within the second cavity.Type: ApplicationFiled: January 7, 2019Publication date: May 9, 2019Applicant: Double Take Containers, LLCInventors: Bradley Joseph Ferraro, Thomas Chadwick Colestock, Christian Paul Bhim
-
Publication number: 20190054053Abstract: The present invention is directed toward fatty acid-based particles, and methods of making such particles. The particles can be associated with an additional, therapeutic agent. Also provided herein is a method of forming fatty acid particles, comprising associating a cross-linked, fatty acid-derived biomaterial with a cryogenic liquid; and fragmenting the bio material/cryogenic liquid composition, such that fatty acid particles are formed. The particles can be used for a variety of therapeutic applications.Type: ApplicationFiled: October 19, 2018Publication date: February 21, 2019Applicant: ATRIUM MEDICAL CORPORATIONInventors: Thomas M. SWANICK, Joseph FERRARO, Lisa ROGERS, Paul MARTAKOS
-
Patent number: 10172486Abstract: A multi-chamber shot container including a hand-held body that defines a first aperture disposed at an upper end of the hand-held body, a second aperture, and an upper fluid aperture disposed at the upper end of the hand-held body, wherein the first aperture and the upper fluid aperture are disposed at the upper end of the hand-held body. The shot container also includes an inner container member with an inner surface and a bottom surface enclosing and defining a first cavity spanning from the bottom surface of the inner container member to the upper fluid aperture and an outer container member with an inner surface and a bottom surface enclosing and defining, with an outer surface of the inner container member, a second cavity liquidly segregated from the first cavity, wherein the first and second apertures are in sole fluid communication with the second cavity.Type: GrantFiled: June 1, 2016Date of Patent: January 8, 2019Assignee: Double Take Containers, LLCInventors: Bradley Joseph Ferraro, Thomas Chadwick Colestock, Christian Paul Bhim
-
Publication number: 20180200306Abstract: A cured non-polymeric gel including a plurality of non-polymeric cross-links. The non-polymeric cross-links result from curing an oil or oil composition at selected curing conditions to achieve a desired amount of cross-linking to form the non-polymeric gel. The desired amount of cross-linking is selected based on a desired rate of degradation of the gel after the gel is implanted. The oil or oil composition comprises one or more of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), or alpha-linolenic acid (ALA).Type: ApplicationFiled: December 14, 2017Publication date: July 19, 2018Applicant: Atrium Medical CorporationInventors: Roger LABRECQUE, Philip MCNAMARA, Joseph FERRARO, Lisa ROGERS, Paul MARTAKOS, Theodore KARWOSKI, Steve A. HERWECK, Keith M. FAUCHER, Thomas M. SWANICK
-
Patent number: 10016465Abstract: A cured non-polymeric gel including a plurality of non-polymeric cross-links. The non-polymeric cross-links result from curing an oil or oil composition at selected curing conditions to achieve a desired amount of cross-linking to form the non-polymeric get. The desired amount of cross-linking is selected based on a desired rate of degradation of the gel after the gel is implanted. The oil or oil composition comprises one or more of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), or alphalinolenic acid (ALA).Type: GrantFiled: October 10, 2014Date of Patent: July 10, 2018Assignee: ATRIUM MEDICAL CORPORATIONInventors: Roger Labrecque, Philip McNamara, Joseph Ferraro, Lisa Rogers, Paul Martakos, Theodore Karwoski, Steve A. Herweck, Keith M. Faucher, Thomas M. Swanick
-
Publication number: 20180168375Abstract: A multi-chamber shot container including a hand-held body that defines a first aperture disposed at an upper end of the hand-held body, a second aperture, and an upper fluid aperture disposed at the upper end of the hand-held body, wherein the first aperture and the upper fluid aperture are disposed at the upper end of the hand-held body. The shot container also includes an inner container member with an inner surface and a bottom surface enclosing and defining a first cavity spanning from the bottom surface of the inner container member to the upper fluid aperture and an outer container member with an inner surface and a bottom surface enclosing and defining, with an outer surface of the inner container member, a second cavity liquidly segregated from the first cavity, wherein the first and second apertures are in sole fluid communication with the second cavity.Type: ApplicationFiled: June 1, 2016Publication date: June 21, 2018Applicant: Double Take Containers, LLCInventors: Bradley Joseph Ferraro, Thomas Chadwick Colestock, Christian Paul Bhim
-
Publication number: 20180133376Abstract: Exemplary embodiments of the present invention provide adhesion barriers having anti-adhesion and tissue fixating properties. The adhesion barriers are formed of fatty acid based films. The fatty acid-based films may be formed from fatty acid-derived biomaterials. The films may be coated with, or may include, tissue fixating materials to create the adhesion barrier. The adhesion barriers are well tolerated by the body, have anti-inflammation properties, fixate, well to tissue, and have a residence time sufficient to prevent post-surgical adhesions.Type: ApplicationFiled: November 17, 2017Publication date: May 17, 2018Applicant: ATRIUM MEDICAL CORPORATIONInventors: Thomas M. SWANICK, Joe BIENKIEWICZ, Joseph FERRARO, Paul MARTAKOS, Keith M. FAUCHER, Alicia DALE
-
Publication number: 20180043065Abstract: Fatty acid-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.Type: ApplicationFiled: October 20, 2017Publication date: February 15, 2018Applicant: ATRIUM MEDICAL CORPORATIONInventors: Keith M. FAUCHER, Hui TANG, Joseph FERRARO, Paul MARTAKOS, Theodore KARWOSKI, Scott CORBEIL
-
Publication number: 20180008650Abstract: A barrier layer and corresponding method of making provide anti-inflammatory, non-inflammatory, and anti-adhesion functionality for a medical device implantable in a patient. The barrier layer can be combined with a medical device structure to provide anti-adhesion characteristics, in addition to improved healing, non-inflammatory, and anti-inflammatory response. The barrier layer is generally formed of a naturally occurring oil, or an oil composition formed in part of a naturally occurring oil, that is at least partially cured forming a cross-linked gel. In addition, the oil composition can include a therapeutic agent component, such as a drug or other bioactive agent.Type: ApplicationFiled: September 20, 2017Publication date: January 11, 2018Applicant: ATRIUM MEDICAL CORPORATIONInventors: Joseph FERRARO, Lisa ROGERS, Paul MARTAKOS, Theodore KARWOSKI, Steve HERWECK, Keith FAUCHER, Phillip MCNAMARA
-
Patent number: 9844611Abstract: Exemplary embodiments of the present invention provide adhesion barriers having anti-adhesion and tissue fixating properties. The adhesion barriers are formed of fatty acid based films. The fatty acid-based films may be formed from fatty acid-derived biomaterials. The films may be coated with, or may include, tissue fixating materials to create the adhesion barrier. The adhesion barriers are well tolerated by the body, have anti-inflammation properties, fixate, well to tissue, and have a residence time sufficient to prevent post-surgical adhesions.Type: GrantFiled: January 20, 2016Date of Patent: December 19, 2017Assignee: Atrium Medical CorporationInventors: Thomas M. Swanick, Joe Bienkiewicz, Joseph Ferraro, Paul Martakos, Keith M. Faucher, Alicia Dale
-
Patent number: 9834346Abstract: A bottle seal breaker cap breaks a foil substrate seal on the top of the body of a medicine or supplement bottle. It has one or more notches, preferably a single notch, extending up from the bottom peripheral lip of a bottle cap, including a cutting surface deep enough to cut into a sealed foil substrate installed for sanitary reasons on top of the body of a medicine or supplement bottle.Type: GrantFiled: September 28, 2015Date of Patent: December 5, 2017Inventor: Joseph Ferraro
-
Patent number: 9827353Abstract: Fatty acid-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.Type: GrantFiled: April 20, 2015Date of Patent: November 28, 2017Assignee: Atrium Medical CorporationInventors: Keith M. Faucher, Hui Tang, Joseph Ferraro, Paul Martakos, Theodore Karwoski, Scott E. Corbeil
-
Patent number: 9801982Abstract: A barrier device is formed of a barrier component that can exhibit anti-inflammatory properties, non-inflammatory properties, and/or adhesion-limiting properties, as well as generate a modulated healing effect on injured tissue. The barrier component can be a non-polymeric cross-linked gel derived at least in part from a fatty acid compound, and may include a therapeutic agent. The barrier device can have anchoring locations to provide an area on the barrier device to interface with an anchoring mechanism. The anchoring locations can include openings and/or anchor elements. The barrier device can also include truss structures that provide additional strength to the barrier component. The barrier device is implantable in a patient for short term or long term applications, and can include controlled release of the therapeutic agent.Type: GrantFiled: March 10, 2008Date of Patent: October 31, 2017Assignee: Atrium Medical CorporationInventors: Steve A. Herweck, Joseph Ferraro, Paul Martakos, Theodore Karwoski, Anthony Richard Horton